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Introduction
Vancomycin is one of the first antibiotic choices for the
treatment of severe gram-positive bacterial infections,
especially if due to methicillin-resistant Staphylococcus
aureus. Vancomycin is suspected to cause nephrotoxi-
city, hence continuous vancomycin therapy as an alter-
native to intermittent administration has been proposed
to reduce the risk of developing acute kidney injury
(AKI). So far, vancomycin concentration and duration of
therapy were identified as the strongest variables asso-
ciated with the development of AKI during continuous
vancomycin therapy [1].
Objectives
To examine the impact of continuous infusion of vanco-
mycin on renal function in critically ill surgical patients.
Methods
With approval by our institutional review board, we retro-
spectively reviewed the data of 139 adult patients (78 men,
61 women; mean age 58 ± 19 years) admitted to the
operative intensive care unit between June 2011 and July
2013 who received continuous infusion of vancomycin for
more than 48 hours. Renal function was assessed by ana-
lyzing serum creatinine levels and urine output from the
first day of vancomycin therapy until 72 hours after its dis-
continuation. Vancomycin concentrations were measured
daily in 78 patients and intermittently in 61 patients; the
mean vancomycin concentration (Cmean) and the maximal
drug concentration (Cmax) were specifically analyzed.
Creatinine clearance was calculated by the Cockcroft-
Gault formula. According to the Acute Kidney Injury
Network, AKI is defined as an increase in the serum crea-
tinine level of ≥ 0.3 mg/dl or ≥ 50 % from baseline or a
daily urine output ≤ 0.5 ml/kg/h. Differences between
patients with and without AKI were assessed using a Stu-
dent’s test for independent variables. In the population of
patients with AKI, a multivariate analysis was performed.
A p-value < 0.05 was considered as statistically significant.
Results
Nineteen patients (14%) developed AKI during the study
period. These patients were significantly older (mean
age 67 vs. 57 years), had a higher morbidity and lower
creatinine clearance on the first day of vancomycin ther-
apy than those who did not develop AKI. Cmax was
independently associated with the development of AKI.
Conclusion
In our study, the rate of AKI during continuous vanco-
mycin therapy was lower than in a previous study in cri-
tically ill patients treated in a medical-surgical intensive
care unit. Our findings should be verified with eligible
prospective studies.
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